Urolithin A activates autophagy to improve liver insulin resistance in diabetic mice
10.7501/j.issn.0253-2670.2020.03.022
- Author:
Ya-Li TIAN
1
Author Information
1. Department of Pharmacology, School of Pharmacy, Xinjiang Medical University
- Publication Type:Journal Article
- Keywords:
Autophagy;
Diabetes;
Insulin resistance;
Insulin signaling pathway;
Urolithin A
- From:
Chinese Traditional and Herbal Drugs
2020;51(3):710-716
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effect of urolithin A (UA) on liver insulin signaling pathway in type 2 diabetes model mice and its relationship with autophagy. Methods: C57BL/6 mice were randomly divided into four groups according to body weight, namely control group, model group, UA (50 mg/kg) group, UA (50 mg/kg) combined with chloroquine (50 mg/kg) group. After 6 weeks of high-fat diet, a type 2 diabetes model was established by ip streptozotocin (STZ). The mice in each group were ig administrated for 7 weeks, and their body weight, water intake, blood lipids, fasting blood glucose (FBG), and fasting insulin (FINS) levels were measured; HE staining was used to observe pathological changes in mouse liver tissue; Western blotting was used to detect mouse phosphorylated protein kinase B (p-Akt), glucose transporter 2 (Glut2), phosphorylated glycogen synthase kinase-3β(p-GSK3β) and autophagy-related protein microtubule-related protein 1 light chain 3 II/I (LC3II/I) and selective autophagy linker protein (p62) expression levels. Results: Compared with the model group, UA significantly improved liver tissue steatosis and edema in diabetic model mice, significantly reduced plasma triacylglycerol, free fatty acids, low-density lipoprotein-cholesterol, FBG, FINS levels, and increased high-density lipoprotein-cholesterol level (P < 0.01); UA significantly reduced HOMA-IR and increased ISI (P < 0.01), up-regulated the protein expression of p-Akt, Glut2, p-GSK3β, and LC3II/I in liver tissues, and inhibited the expression of p62 protein (P < 0.01). Combined with chloroquine, FBG, FINS, and HOMA-IR in mice were increased, and ISI was decreased (P < 0.05); Liver tissue edema and steatosis were significantly aggravated; The expression levels of p-Akt, Glut2, LC3II/I protein in liver tissue were decreased, and p62 protein expression levels were increased (P < 0.05), indicating that the autophagy inhibitor chloroquine significantly weakened the effect of UA. Conclusion: UA may improve liver insulin resistance in diabetic mice by activating liver autophagy.
